Company Description
Generex Biotechnology knows that needles can be a real pain for diabetics, so it has developed Oral-lyn, an oral insulin spray that allows the...
Key Generex Biotechnology Financials
| Company Type | Public - NASDAQ (CM): GNBT Main Headquarters |
|---|---|
| Fiscal Year-End | July |
| 2009 Sales (mil.) | $1.1 |
| 2009 Employees | 43 |
More Generex Biotechnology Financials (9 pages)
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Generex Biotechnology's competition across multiple industries
Top Generex Biotechnology Competitors
Sponsored Links
The Business DirectoryGenerex Biotechnology Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairperson, President, and CEO | Anna E. Gluskin | Network |
| COO, CFO, Treasurer, Secretary, and Director | Rose C. Perri | Network |
| Senior Executive Advisor Global Business Development and Licensing | William (Bill) Abajian | Network |
More Generex Biotechnology Executives
| Searching for B2B Sales Leads? | ||
|---|---|---|
| With Hoover's Lead Builder, you can build, purchase, and download accurate, up-to-date lists of business leads for your direct mail and telemarketing campaigns. |
Tools from our advertising partners:
